v3.26.1
Equity (Tables)
 12 Months Ended
Dec. 31, 2025
Equity [Abstract]  
Schedule of Share Capital Composition of share capital:
   December 31, 2025   December 31, 2024 
   Authorized   Issued and
outstanding		   Authorized   Issued and
outstanding		 
   Number of shares 
Ordinary shares   75,000,000    365,444    75,000,000    57,293 
Schedule of Issued and Outstanding Share Capital

Issued and outstanding share capital:

 

   Number of
ordinary
shares		 
     
Balance at January 1, 2024   3,739 
      
Issuance of share capital – in respect of exercise of October 2023 pre-funded warrants  (Note 18g)   19,457 
      
Shares issued to consultants (Note 19(a)(3))   3,419 
      
Issuance of share capital – in respect of January 2024 SEPA (Note 18(h))   30,678 
      
Balance at December 31, 2024   57,293 
      
Shares issued to consultants in respect of exercised restricted share units (“RSUs”) (Note 18e)   4,205 
      
Exercise of convertible debentures (Note 18i)   119,094 
      
Exercise of warrants (Note 18j)   40,172 
      
Issuance of shares in a registered direct offering (Note 18k)   143,617 
      
Shares issued to consultants (Note 19(a)(3))   1,059 
      
Rounding shares   4 
      
Balance at December 31, 2025   365,444 
Schedule of Outstanding Warrants The following table summarizes information of outstanding warrants as of December 31, 2025:
Warrants  Warrant Term  Exercise Price  Exercisable 
               
March 2021 Series A Warrants  March 1, 2026  USD   34,743    233 
March 2021 Series B Warrants  March 1, 2026  USD   52,088    117 
May 2022 Warrants  May 27, 2027  USD   12,924    1,443 
               1,793